SINGAPORE, Nov. 19, 2013 / PRNewswire / - Zecotek Photonics Inc. (TSXV: ZMS) (OTCPK: ZMSPF) (Frankfurt: W1I), a developer of leading photonics technologies for the medical, industrial and scientific markets, today announced its 100th anniversary % Subsidiary Zecotek Imaging Systems Pte. Ltd. has received an order worth US $ 6965 from its strategic partner Hamamatsu Photonics (Tokyo: 1.500.000) in Japan for its patented Lutetium Fine Silicate (LFS) scintillation crystals. This second order for LFS scintillation crystals is for use in medical positron emission tomography (PET) scanners from third-party original equipment manufacturers.
"Hamamatsu is actively involved in the commercialization of Zecotek's patented LFS scintillation crystals," Dr. AF Zerrouk, Chairman, President and CEO of Zecotek Photonics Inc. "PET manufacturers recognize the cost / performance / IP benefits of using LFS scintillation crystals. I am very satisfied with the efforts of our strategic partner. LFS technology received attention at the recent Nuclear Science Symposium and IEEE Conference meeting in Seoul, South Korea, and was presented to thousands of Hamamatsu customers at the Photon Fair in Japan in November. Our joint imaging projects are already well advanced. "
On the 16. In July 2013, Zecotek and Hamamatsu announced their strategic partnership for the commercialization of existing imaging technologies and for collaboration in the upgrading and manufacturing of photodetectors, integrated detector modules and associated electronics and data acquisition modules for the imaging market in general. Hamamatsu is the world's leading supplier of optoelectronic components including photomultiplier tubes (PMTs) and photodiodes for use in medical positron emission tomography (PET) scanners, in European Organization for Nuclear Research projects (CERN) and in other industrial and scientific applications.
Zecotek's patented LFS series of scintillation crystals (US Patent Number 7.132.060) is known for its high luminous efficacy and ultra-fast cooldowns, enabling faster and more high-resolution operation of medical and industrial imaging equipment such as medical PET scanners. Zecotek's range of LFS crystals also covers a wide range of emission wavelengths that can be tuned to the spectral sensitivity of various photodetectors, including MAPD solid-state detectors.
The LFS scintillation crystals are manufactured by the contracted Beijing Opto-Electronics Technology Company (BOET), a subsidiary of the North-China Research Institute of Electronics Optics and market leader in the breeding, separation and large scale production of scintillation crystals using the Czochralski process. Zecotek's manufacturing process makes it possible to grow single crystal bodies of large diameter, uniformity and no cracking (a problem with many competing scintillation materials), resulting in high element yield and lower unit cost.
About Hamamatsu Photonics KK
Hamamatsu Photonics KK (Japan) is a leading manufacturer of equipment for the generation and measurement of infrared, visible and ultraviolet light. These devices include photomultiplier tubes, scientific light sources, opto-semiconductors, cameras, and specialized imaging systems. Hamamatsu Photonics is dedicated to advancing photonics through in-depth research. This business philosophy results in the production of state-of-the-art products used worldwide in scientific, industrial and commercial applications.
About Zecotek
Zecotek Photonics Inc. (TSX-V: ZMS, Frankfurt: W1I) is a photon technology company that provides advanced high-performance scintillation crystals, photodetectors, positron emission tomography inspection technologies, 3D autostereoscopic displays and lasers for medical, high-tech applications. and industry developed. Founded in 2004, Zecotek operates three divisions: Imaging Systems, Laser Systems and 3D Display Systems with laboratories in Canada, Korea, Russia, Singapore and the US. The management team is focused on increasing enterprise value through the commercialization of 50 patented and patent pending novel photonic technologies, either by themselves or through strategic alliances and joint ventures with leading industrial partners such as the European Organization for Nuclear Research (CERN) (Switzerland), Beijing Opto-Electronics Technology Co., Ltd. (China), NuCare Medical Systems (South Korea) and the National NanoFab Center (South Korea). For more information visit www.zecotek.com. Follow us on Twitter (@zecotek) or on Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements based on management's expectations, estimates, forecasts and opinions. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. The actual results and trends may therefore differ materially from the statements made here.
The TSX Venture Exchange and its regulators (referred to in the Articles of Incorporation of the TSX Venture Exchange as Regulation Services Providers) accept no responsibility for the adequacy or accuracy of the contents of this news release. If you would like to receive the most up-to-date information about Zecotek in the future, please visit our company's website at www.zecotek.com.
No liability is assumed for the accuracy of the translation! Please note english original message!
Source: IRW-Press.com.
